Serotnin as a possible biomarker in obstructive sleep apnea

Melissa C. Lipford, Kannan Ramar, Yao Jen Liang, Chii Wann Lin, Yun Ting Chao, Jen An, Chih Hsien Chiu, Yi Ju Tsai, Chih Hung Shu, Fei Peng Lee, Rayleigh Ping Ying Chiang

研究成果: 雜誌貢獻文章同行評審

9 引文 斯高帕斯(Scopus)


Obstructive sleep apnea (OSA) is a highly prevalent disease which carries substantial public health burden. Polysomnography is the standard procedure used to diagnose OSA. However cost, accessibility, technical requirements, and skilled interpretation needs constrain its widespread use and have a role in the under-diagnosis of sleep disordered breathing. There is a clinical need to develop expedient and widely accessible tools to detect this disorder., Several biochemical markers have recently been proposed as diagnostic tools in OSA. Numerous neurochemicals directly influence the activity of upper airway dilator motor neurons, which subsequently influence respiration during sleep. Serotonin (5-HT) is one such neurochemical that has a key role in ventilatory stimulation. Herein, we review the current evidence demonstrating relationships between multiple biomarkers and sleep disordered breathing and focus on relationships between OSA and 5-HT. We discuss the possibility of biomarker-driven detection technology in the future as a means of diagnosing and monitoring OSA. Finally, we explore the specific role 5-HT may have in the future in both the diagnosis and treatment of OSA.

頁(從 - 到)121-128
期刊Sleep Medicine Reviews
出版狀態已發佈 - 8月 1 2016

ASJC Scopus subject areas

  • 神經病學(臨床)
  • 生理學(醫學)
  • 肺和呼吸系統醫學
  • 神經內科


深入研究「Serotnin as a possible biomarker in obstructive sleep apnea」主題。共同形成了獨特的指紋。